tiprankstipranks
Advertisement
Advertisement

ALLO Stock Latest News

Allogene Therapeutics Announces Retirement of Chief Financial Officer
Company AnnouncementsAllogene Therapeutics Announces Retirement of Chief Financial Officer
19h ago
8K
ALLO
Allogene Therapeutics CFO Geoffrey Parker to retire
PremiumThe Fly
Allogene Therapeutics CFO Geoffrey Parker to retire
20h ago
ALLO
Allogene Therapeutics Signals Progress Amid Key Risks
PremiumCompany Announcements
Allogene Therapeutics Signals Progress Amid Key Risks
11d ago
ALLO
Allogene Therapeutics files $500M mixed securities shelf
PremiumThe Fly
Allogene Therapeutics files $500M mixed securities shelf
17d ago
ALLO
Allogene Therapeutics reports Q2 EPS (13c), consensus (15c)
PremiumThe Fly
Allogene Therapeutics reports Q2 EPS (13c), consensus (15c)
17d ago
ALLO
Tyler Van Buren Reiterates Buy on Allogene, Citing Strong ALPHA3 Trial Momentum and De-Risking Efficacy/Safety Data for Off-the-Shelf CAR-T Cema-cel
PremiumRatingsTyler Van Buren Reiterates Buy on Allogene, Citing Strong ALPHA3 Trial Momentum and De-Risking Efficacy/Safety Data for Off-the-Shelf CAR-T Cema-cel
21d ago
ALLO
Allogene Therapeutics (ALLO) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Allogene Therapeutics (ALLO) Q2 Earnings Cheat Sheet
24d ago
ALLO
Allogene gets RMAT, Fast Track designations for cemacabtagene ansegedleucel
Premium
The Fly
Allogene gets RMAT, Fast Track designations for cemacabtagene ansegedleucel
1M ago
ALLO
Allogene publishes Phase 1 data in Journal of Clinical Oncology
PremiumThe Fly
Allogene publishes Phase 1 data in Journal of Clinical Oncology
2M ago
ALLO
Citizens biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Citizens biotech analyst holds an analyst/industry conference call
2M ago
ALLO
CLLS
Citizens biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens biotech analysts hold an analyst/industry conference call
2M ago
ALLO
CLLS
Allogene Launches ATM Offering to Bolster Capital Flexibility
PremiumCompany Announcements
Allogene Launches ATM Offering to Bolster Capital Flexibility
2M ago
8K
ALLO
Allogene Therapeutics Names Zachary Roberts as New CEO
PremiumCompany AnnouncementsAllogene Therapeutics Names Zachary Roberts as New CEO
3M ago
8K
ALLO
Allogene Therapeutics says Zachary Roberts to succeed David Chang as CEO
Premium
The Fly
Allogene Therapeutics says Zachary Roberts to succeed David Chang as CEO
3M ago
ALLO
Allogene Earnings Call Highlights Early CAR-T Momentum
Premium
Company Announcements
Allogene Earnings Call Highlights Early CAR-T Momentum
4M ago
ALLO
Allogene Therapeutics Balances Bold Data With Rising Spend
PremiumCompany Announcements
Allogene Therapeutics Balances Bold Data With Rising Spend
4M ago
ALLO
Allogene’s UNIVERSAL Trial Completion: What ALLO-715 Data Could Mean for Investors
PremiumCompany Announcements
Allogene’s UNIVERSAL Trial Completion: What ALLO-715 Data Could Mean for Investors
4M ago
ALLO
Allogene Therapeutics reports Q1 EPS (18c), consensus (18c)
PremiumThe Fly
Allogene Therapeutics reports Q1 EPS (18c), consensus (18c)
4M ago
ALLO
Allogene Highlights ALPHA3 Data and Extended Cash Runway
PremiumCompany Announcements
Allogene Highlights ALPHA3 Data and Extended Cash Runway
4M ago
8K
ALLO
Allogene Therapeutics increases 2026 operating cash expense guidance
PremiumThe FlyAllogene Therapeutics increases 2026 operating cash expense guidance
4M ago
ALLO
Allogene Therapeutics options imply 10.6% move in share price post-earnings
Premium
The Fly
Allogene Therapeutics options imply 10.6% move in share price post-earnings
4M ago
ALLO
ALLO Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ALLO Upcoming Earnings Report: What to Expect?
4M ago
ALLO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >